Pfizer Ltd is engaged in manufacturing, marketing, trading and export of pharmaceutical products. It manufactures products through its own facility and also has various independent contract/ third party manufacturers based across the country and sells its products through independent distributors primarily in India. It is the 3rd largest multinational pharmaceutical company in India.
Financial Results:
Pfizer Ltd reported Revenues for Q4FY25 of ₹592.00 Crores up from ₹547.00 Crore year on year, a rise of 8.23%.
Total Expenses for Q4FY25 of ₹383.00 Crores up from ₹378.00 Crores year on year, a rise of 1.32%.
Consolidated Net Profit of ₹331.00 Crores up 84.92% from ₹179.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹72.34, up 85.01% from ₹39.10 in the same quarter of the previous year.